Serum hepcidin and erythropoietin in relation to anemia in non-diabetic chronic kidney disease: a cross-sectional study
Mostafa Gamal, A. M. Abdel-Rahman, Ahmed Abd Elwahab, Huda Refaie, Sawsan M. El-Halawani, Wael l. Mortada, Mohamed Sobh · 2026
Read Serum hepcidin and erythropoietin in relation to anemia in non-diabetic chronic kidney disease: a cross-sectional study by Mostafa Gamal, A. M. Abdel-Rahman, Ahmed Abd Elwahab, Huda Refaie, Sawsan M. El-Halawani, Wael l. Mortada, Mohamed Sobh (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13570887.txt.
Description
Mostafa Gamal and co-authors studied two blood hormones in relation to anemia in one hundred patients with chronic kidney disease who did not have diabetes. Failing kidneys disrupt iron handling and red blood cell production, causing anemia. One hormone, hepcidin, locks iron away, while the other drives the bone marrow to make red cells.
All patients were treated at a university center in Mansoura, Egypt. None had received iron supplements or marrow-stimulating drugs before, which removes two big sources of confusion. Blood tests measured both hormones along with hemoglobin and iron markers. Untangling how the two hormones interact in untreated patients can sharpen anemia care in kidney clinics.
Catalog record
| CREATOR | Mostafa Gamal, A. M. Abdel-Rahman, Ahmed Abd Elwahab, Huda Refaie, Sawsan M. El-Halawani, Wael l. Mortada, Mohamed Sobh |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |